Echinacea Purpurea Research Articles

The addition of vermicompost and biostarter affects the growth, total phenolic and antioxidant activity of Echinacea purpurea

Abstract. Choirunnisa LF, Widiayastuti Y, Solichatun, Yunus A. 2022. The addition of vermicompost and biostarter affects the growth, total phenolic and antioxidant activity of Echinacea purpurea. Nusantara Bioscience 14: 148-154. Echinacea purpurea (L.) Moench or purple coneflower is a medical plant that originated in North America and contained various bioactive compounds, one of which is phenolic. Applying organic fertilizer like vermicompost has been reported to increase plants' bioactive compounds' components and antioxidant activity. The purpose of this study was to determine the addition of vermicompost and biostarter on the growth, total phenolic and antioxidant activity of E. purpurea. Split-Plot Randomized Complete Block Design was used with dosages of vermicompost 0, 40, 60, and 80 g/plant and different types of biostarter from Banana peel waste and effective microorganisms (EM). The results showed that treatment of 80 g/plant vermicomposts and EM highest resulted in the growth rate parameters (plant high, leaf numbers, leaf area, roots volume, plant fresh and dry weight) and total phenolic content with 1.802%. On the other hand, the herb extracts had the highest result with the treatment of 40 g/plant vermicomposts and EM (4.96%). The antioxidant activity was tested using the DPPH method with TLC and showed that all treatments indicated positive antioxidant activity.

Oxidation during Fresh Plant Processing: A Race against Time

Oxidation is a major concern in the food and cosmetics industry; however, little information is available in the literature about its effect during the production of herbal medicines. The impact of oxidation on herbal mother tincture (MT) manufacturing was investigated by performing an oxidative stress test, in which cryogenically ground fresh plants (Echinacea purpurea, Mentha piperita, Ginkgo biloba, and Hypericum perforatum) were exposed to air in a time-controlled manner before extraction. The effect of oxidation on the resulting extracts was evaluated using UV–Vis spectroscopy and potassium permanganate antioxidant assay. Furthermore, a tyrosinase enzymatic assay was performed on MTs to evaluate the behavior of the absorbance spectra of phenolic compounds during oxidation. Additionally, several commercially available herbal mother tinctures were examined for oxidative changes. The exposure of the fresh plant material to air for 30 min decreased the antioxidant activity in all four tested plants by 10% to 44%. This decrease occurred along with an intensity diminution and flattening of the typical UV–Vis absorption spectra of the MTs. The results have shown that the impact of oxidation during MT manufacturing is a serious issue and could be monitored by means of simple UV–Vis spectra recording.

Polysaccharide from Echinacea purpurea plant ameliorates oxidative stress-induced liver injury by promoting Parkin-dependent autophagy

Background: Acetaminophen (APAP) overdose represents one of the most common drug-induced liver injuries (DILI) worldwide. Oxidative damage to the hepatocytes and their resultant autophagy are the key components in the APAP-induced DILI. Echinacea purpurea polysaccharide (EPPS), the component extracted from the root of Echinacea purpurea (L.) Moench, shows various biological functions including immunoregulation and antioxidant activity.Purpose: This study aimed to elucidate the protective effect of EPPS against APAP-induced DILI and the underlying mechanisms. Results: EPPS attenuates APAP overdose induced DILI in mice and ameliorates inflammation and oxidative stress in mice with APAP overdose-induced DILI. Furthermore, EPPS protected the hepatocytes against APAP-induced liver injury by suppressing apoptosis. EPPS ameliorates APAP-induced DILI via an autophagy-dependent mechanism in vivo and increases autophagy with a reduction in oxidative stress and inflammation in vitro. Parkin knockdown prevents the autophagic-dependent manner of EPPS effects in APAP-treated hepatocytes.Conclusions: EPPS exhibited a strong hepatoprotective effect against APAP-induced DILI and was correlated with reduction of autophagy-dependent oxidant response, inflammation, and apoptosis. Moreover, the findings indicated that EPPS exerts its hepatoprotective effect against APAP mainly via Parkin-dependent autophagy, and the use of EPPS can serve as a promising novel therapeutic strategy for APAP-induced DILI.

Rational and Safe Use of the Top Two Botanical Dietary Supplements to Enhance the Immune System.

The recent COVID-19 pandemic has sparked great interest in strengthening the immune system, especially by the consumption of widely available natural dietary supplements. Because of this popularity, it was suggested that the sales of these products would grow significantly in the year 2021, especially for those who are unable or unwilling to receive COVID-19 vaccines. Among the many botanicals, Sambucus nigra L. (Elderberry) and Echinacea purpurea (L.) Moench (Echinacea) have especially shown great popularity. Various in vivo and in vitro tests of S. nigra and E. purpurea extracts and constituents have confirmed the botanicals' influence on proinflammatory cytokines, viral infections, and flu symptoms, proving their immunomodulatory and antiviral effects. Although there have been promising results with S. nigra and E. purpurea containing supplements, thorough monitoring of the sanitary production, demand, and related side effects after consumption is required. Further research and development of the supplements in accordance with the pandemic are also advised.

The intestinal absorption mechanism of chicoric acid and its bioavailability improvement with chitosan

Chicoric acid (CA), an active phenolic acid of Echinacea purpurea (Linn.) Moench, has been demonstrated to exhibit antioxidative, antiviral and immunological activities. A prior study showed that CA is a water-soluble compound with low bioavailability. The current study was performed to study the intestinal absorption mechanism of CA and improve its bioavailability using natural biodegradable chitosan. A Caco-2 monolayer cell model was established to characterise the mechanisms involved in the intestinal absorption of CA. The bioavailability improvement of CA was studied in Sprague–Dawley rats after oral (20 mg/kg) administration of 0.5% chitosan. In vitro, the results showed that the absorption transport of CA was fairly poor, with Papp values of 8.2 × 10−8 to 2.1 × 10−7 cm/s in the absorption direction and 1.5 × 10−7 to 2.6 × 10−7 cm/s in the secretory direction. The permeability was increased by EDTA and chitosan in both directions. Moreover, the transport through the intestinal monolayer was H+ dependent, and P-glycoprotein and OATP2B1 transporters were involved in the intestinal transport of CA. In vivo, the absorption of CA was increased and accelerated with chitosan in rats because the bioavailability was 1.74-fold that of the prototype drug. The above mentioned results indicated that CA was a poor absorption drug and that paracellular and carrier-mediated trancellular transport both participated in its transport route. Chitosan is an excellent absorption enhancer for CA. The transport characteristics uncovered in this study lay the groundwork for further studies directed toward the development and utilisation of its new formulations.

Анатомическое строение язычкового цветка Echinacea purpurea (L.) Moench

The article presents the results of scientific research on the determination of the anatomical structure of the reed flower Echinacea purpurea (L.) Moench introduced in South Kazakhstan. To prepare the micropreparation, the lingual flowers of the plant were taken; they are purple, 2.5–6 cm long, inner 4 mm long. The films of the flower are lanceolate awl-shaped, 1–1.5 cm long, 1–1.5 mm wide, with a straight prickly tip. Previously, the anatomical structure of the leaf, stem and root of Echinacea purpurea were studied. The purpose of the study is to examine the anatomical structure of the lingual flower of E. Purpurea to identify diagnostic signs characteristic of this type, necessary for the development of effective and lowtoxic domestic drugs. Information about the anatomical features of the generative organs of the studied species is given for a complete diagnosis of medicinal plant raw materials, which can be seen in microphotographs taken by a computer microphotometer. The following anatomical features necessary for the identification of raw materials have been identified, i.e., signs by which the studied object can be distinguished from similar parts of another plant: the outline of epidermal cells on the adaxial structure is rectilinear, the projection is polygonal, on the abaxial — weakly branched; stomata are not submerged, anomocytic type; the structure of the mesophyll of the lingual flower is aerenchyma with well-defined intercellular lacunae; the presence of lamellar collenchyma under the abaxial epidermis; conducting bundles are closed collateral; the location of schizogenic secretory receptacles above conducting bundles.

METHODICAL APPROACH TO THE DETERMINATION OF THE ANTIOXIDANT ACTIVITY OF THE ECHINACEA PURPUREA AND MONARDA FISTULOSA TINCTURES AS A QUALITY CRITERION OF THE DEVELOPMENT OF THEIR COMPOSITION AND LABORATORY TECHNOLOGY

Aim. The aim of the study was to develop the methodical approach to determine the antioxidant activity of the tinctures of Monarda fistulosa herb and flowers and roots of Echinacea purpurea, as well as to develop their technology in laboratory conditions.
 Materials and Methods. The following methods were used: analysis, synthesis, systematization, and comparison for processing of published scientific data on antioxidant activity; method for measuring the particle size of raw herbal materials; maceration and remaceration methods for obtaining the tested tinctures; DPPH test for the valuation of the antioxidant activity of the developed tinctures.
 Results and Discussion.
 The methodical approach to determining the antioxidant activity of the tinctures of Monarda fistulosa herb and flowers and roots of Echinacea purpurea was elaborated, the essence of which consisted in the selection of the appropriate dilution of the tinctures. Tinctures were prepared with the help of maceration or/and remaceration in laboratory conditions. The ratios of herbal raw materials (HRM) to the final tincture were close to ratios that are widely employed in the pharmaceutical industry, namely 1 to 5 and 1 to 10. The coefficients of alcohol absorption for the roots of Echinacea purpurea (size 2-5 mm), flowers of Echinacea purpurea (size 1-3 mm), herb of Monarda fistulosa (size 0.5-3 mm) were measured. They were measured as 1.2, 2.25, and 5.0 ml/g, respectively, for 70% ethanol. The studies revealed that Echinacea purpurea tinctures are a valuable source of antioxidant compounds. The antioxidant activity of these tinctures was 254.8-815.8 mg rutin-equivalents in 1 L of the tinctures or 1.12-4.43 mg rutin-equivalents in 1 g of the HRM depending on the part of the plant, particle size and extraction type. The antioxidant activity of the tinctures of the Monarda fistulosa herb was equal to 2203.6 mg eq-rutin/L and 20.3 mg eq-rutin/g for the tincture and HRM at a ratio of 1 to 9.5 and 2119.4 mg eq-rutin/L and 9.7 mg eq-rutin/g for the tincture at a ratio of 1 to 4.5.
 Conclusions. The approach to the determination of the antioxidant activity of the tested tinctures was elaborated, namely the dilutions of the tinctures were established for the analytical procedure of the determination of the antioxidant activity. Our studies demonstrated that tinctures of Echinacea purpurea contained compounds with antioxidant activity. The tinctures of Monarda fistulosa herb are very rich in compounds with antioxidant properties. The laboratory technology of six tinctures was elaborated. Further studies will be directed at laboratory studies on microorganisms and animals.

Влияние физических факторов на жизнеспособность семенного материала Echinacea purpurea сорт «Ливадия»

This article presents data on the germination of Echinacea purpurea seeds of the variety “Livadia” as a result of the influence of physical factors. The seed material was previously cryogenically stored for a day, then the seeds were exposed to laser irradiation and magnetic fields for a certain time, and the bubbling method was also used in the experiment. As a result of the conducted studies, it was found that seeds exposed to magnetic fields retain their viability, but there is no improvement in germination indicators compared to the control group. Positive dynamics in seed germination and the passage of ontogenesis phases were observed in experimental variants with preliminary cryogenic storage of seeds and subsequent bubbling for one day, germination rates were comparable with control values. The seed material irradiated with a He-Ne laser beam showed a decrease in germination rates compared to the control group.

Chicoric Acid: Natural Occurrence, Chemical Synthesis, Biosynthesis, and Their Bioactive Effects.

Chicoric acid has been widely used in food, medicine, animal husbandry, and other commercial products because of its significant pharmacological activities. However, the shortage of chicoric acid limits its further development and utilization. Currently, Echinacea purpurea (L.) Moench serves as the primary natural resource of chicoric acid, while other sources of it are poorly known. Extracting chicoric acid from plants is the most common approach. Meanwhile, chicoric acid levels vary in different plants as well as in the same plant from different areas and different medicinal parts, and different extraction methods. We comprehensively reviewed the information regarding the sources of chicoric acid from plant extracts, its chemical synthesis, biosynthesis, and bioactive effects.

Morphological, phytochemical, and essential oil changes induced by different nitrogen supply forms and salinity stress in Echinacea purpurea L.

Salinity is one of the most important environmental factors that affect the plants growth and phytochemical compounds. So, this study was aimed to investigate the effect of salinity stress (15 mM, 30 mM, and 60 mM NaCl) and different NO3−/NH4+ ratios (90:10; 80:20, and 70:30) on Echinacea purpurea properties in greenhouse conditions. A wide range of morphological properties and phytochemical compounds were determined based on the standard methods. Essential oil analyses was performed by using GC-Mass spectrometer. According to the results, plant height, total biomass, and fresh root weight decreased by 49.6, 43.2, 40.5% after the application of 60 mM NaCl, compared with control plants. However, an increase in total leaf phenolic content, flavonoid content, PAL enzyme activity, super oxide, and nitric oxide anti-radical scavenging activities by 44, 37.2, 57.9, 46, and 27.2% were found in plants grown under 30 mM NaCl salt stress conditions, respectively compared with control plants. The major terpene hydrocarbons found in the E. purpurea extract were germacrene D (60.3%), myrcene (19.8%), α-pinene (13.1%), β-caryophyllene (12.3%), and 1-Pentadecene (5.1%), respectively. It can be concluded that, 30 mM NaCl and 90:10 NO3−/NH4+ ratio are effective for improving phytochemical properties of E. purpurea.

Nephroprotective role of Echinacea purpurea against potassium dichromate-induced oxidative stress, inflammation, and apoptosis in rats.

Environmental and occupational exposure to chromium compounds, especially hexavalent chromium [Cr(VI)], is widely recognized as a potential nephrotoxic in humans and animals. Its toxicity is associated with the overproduction of free radicals, which induces oxidative damage. Echinacea purpurea (L.) Moench is an herbaceous perennial plant rich in phenolic components and frequently used for its medicinal benefits. The current work evaluated the effectiveness of E. purpurea (EP) against oxidative stress and nephrotoxicity induced by potassium dichromate in male rats. Male Wistar rats were divided into four groups: control, E. purpurea (EP; 50 mg/kg; once daily for 3 weeks), hexavalent chromium (Cr(VI); 15 mg/kg; single intraperitoneal dose), and EP + Cr(VI) where rats were pretreated with EP for 3 weeks before receiving CrVI, respectively. Results revealed that rats exposed to Cr(VI) showed a significant increase in PC, TBARS, and H2 O2 , kidney function biomarkers (Urea, creatinine, and uric acid), lactate dehydrogenase activity (LDH), TNF-α, IL-18, nuclear factor kappa B (NFκB), and IGF-1 (Insulin-like growth factor-1) levels as well as a considerable decline in metallothionein (MT), glutathione (GSH) content, enzymatic antioxidants (SOD, CAT, GPx, GR, and GST), alkaline phosphatase (ALP) activities, and protein content. Cr(VI) induced apoptosis in kidney tissues as revealed by upregulation of Bax and caspase 3 and downregulation of Bcl-2. Furthermore, EP treatment ameliorated the Cr(VI)-induced histopathological and ultrastructure variations of kidney tissue, which was confirmed by the biochemical and molecular data. It is clear from the results of this study that EP exerts nephroprotective effects by improving the redox state, suppressing inflammatory reaction and cell apoptosis as well as ameliorating the performance of kidney tissue architecture, which is eventually reflected by the improvement of kidney function in rats.

Non-antibiotic Prophylaxis of Infections

Non-antibiotic Prophylaxis of Infections Abstract. The increasing resistance to antibiotics makes the search for non-antibiotic alternatives for the treatment and prevention of - above all - respiratory and urinary tract infections crucial. Potential non-antibiotic approaches include phytopharmaceuticals (Echinacea purpurea, Pelargonium sidoides, cranberry extract), zinc, immunostimulants (OM-85 BV, OM-89), and behavior modifications. Some of these approaches are promising options; however, a high level of evidence is required before specific recommendations for their use can be made.

Ziołolecznictwo w infekcjach wirusowych

The study is a review of natural raw materials that can prevent infection and help treat viral infections, including those that cause COVID-19. The condition of not getting infected with pathogens that cause infections of the upper and lower respiratory tract is high the body resistance. An important element that influences the proper immunity of the body is the diet. The functioning of the immune system is improved by bee products, and plant materials: purple coneflower herb, flower and root, licorice root, aloe gel and Baikal skullcap root, as well as black cumin seed oil, chaga mushroom, lemon balm leaves and chamomile flowers. Strengthening immunity is conducive to maintaining a good mood and reducing stress. The antiviral activity has been confirmed for many plant materials, especially those containing essential oils. Natural products can be used for prevention and treatment. The country that copes best with the coronavirus epidemic is China, thanks to a combination of academic and natural medicine. The study quotes an excerpt from the “Handbook of COVID-19 Prevention and Treatment”, prepared by Chinese doctors, with particular attention to the recipes used by them.

Promotion effect of graphene on phytoremediation of Cd-contaminated soil.

Echinacea purpurea (L.) Moench was selected as a remediation plant in this study, and different concentrations of graphene oxide (GO) were added to Cd-contaminated soil. Through pot experiments, the effect of E. purpurea on Cd-contaminated soil was determined at 60 days, 120 days, and 150 days. A preliminary study on the remediation mechanism of GO was explored through changes in the forms of Cd in the rhizosphere soil, soil pH, and soil functional groups. Results showed that the optimal concentration of GO was 0.4 g/kg, and under the condition, the accumulation of Cd in the roots of E. purpurea was as high as 113.69 ± 23.86 mg/kg, and the maximum EF reached 5.87 ± 1.34. Compared with those of the control group, accumulated Cd concentration and EF in the roots increased by 60.34% and 2.32, respectively. Correlation analysis showed that the absorption and accumulation of Cd was negatively correlated with the exchangeable Cd content at 120 days, and the exchangeable Cd was negatively correlated with the relative content of functional groups in the soil with 0.4 g/kg GO (E2). The artificial application of GO to the soil can be used as an effective way to improve the effect of E. purpurea in the remediation of Cd soil pollution, and it has great application potential in the stabilization of plants and vegetations and restoration of high-concentration Cd-contaminated soil.

Optimization of heat and ultrasound assisted extraction of bioactive compounds from Echinacea purpurea using response surface methodology

The optimal conditions for extracting phytochemical from plant materials is a critical step in herbal medicine industry. In the present study, the optimal conditions for extracting the maximum amount of E. purpurea chicoric acid, total phenolics, and antioxidant activity were obtained by response surface methodology (RSM). A D-optimal design of extracting factors including temperature (25–75 °C), sonication time (0–60 min), solvent concentration (0–100%), and solvent types (methanol and ethanol) was generated. Results showed that solvent concentration, solvent types, temperature and sonication times are respectively the most significant factors when all responses were considered. The optimal extraction conditions were found as follows: 75 °C temperature, 51.8 min sonication, and 41.70% methanol with a desirability of 0.982. The optimum condition was repeated five times and the average amount of chicoric acid, total phenolics, and antioxidant activity were 26.09 mg/g, 47.31 mg/g, and 56.94%, respectively, which were in accordance with the optimized predicted values (p < 0.05). In comparison with the optimal conditions obtained in this research, traditional brewing methods cause the loss of more than 50% of bioactive compounds.

Echinacea angustifolia and Echinacea purpurea Supplementation Combined with Vaginal Hyaluronic Acid to Boost the Remission of Cervical Low-Grade Squamous Intraepithelial Lesions (L-SILs): A Randomized Controlled Trial.

Background and Objectives: Echinacea angustifolia and purpurea have known immunomodulatory effects which boost viral clearance, including HPV infection. However, evidence regarding the improvement due to Echinacea-based supplements of cervical HPV-related pathologies is still lacking. The aim of this study is to evaluate the efficacy of Echinacea supplementation on the remission of cervical low-grade squamous intraepithelial lesions (L-SIL). Materials and Methods: A single-blind 1:1:1 parallel randomized controlled trial was conducted at the Colposcopy Unit of a tertiary care referral center. Reproductive-aged women were allocated either to (a) an oral supplement based on Echinacea extracts plus vaginal hyaluronic acid-based soft gel capsules, (b) the Echinacea supplement alone, or (c) vaginal hyaluronic acid-based soft gel capsules alone for 3 months. The primary outcome was the regression of cervical intraepithelial neoplasia (CIN)-1 for each treatment arm at 3, 6 and 12 months after the diagnosis. Secondary outcomes included changes in the epithelialization, pap smear, colposcopic parameters, histological reports, and vaginal health indexes (VHI) in the study groups. Results: 153 women (52 for arm A, 50 for arm B and 51 for arm C) completed the follow-up and were included in the analysis. There were no significant differences in both primary and secondary outcomes for the three groups after 3 months. At the 6-month follow-up, the number of persistent CIN-1 diagnoses was significantly lower in arm A (15/51), rather than in arm B (23/48, p = 0.03) and C (27/49, p = 0.03). Similarly, the same effect was seen after 12 months for treatment A (5/51) relative to B (15/48, p = 0.03) and C (14/48, p = 0.03). Colposcopic, histological and vaginal parameters were all significantly improved at 6 and 12 months for arm A relative to B and C, while no beneficial effects were seen after 3 months. Conclusions: Echinacea extracts supplementation in women with L-SIL/CIN-1 significantly boosts HPV lesion clearance, reducing the overall amount of diagnosis, histological, colposcopic and vaginal parameters after 6 and 12 months. However, a limited sample size reduces the quality of evaluated evidence, emphasizing the need for additional studies to validate these findings.

Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review.

Echinacea purpurea (L.) Moench (EP)is a perennial herbaceous flowering plant, commonly known as purple coneflower and it belongs to the Asteraceae family. The Echinacea genus is originally from North America, in the United States, and its species are widely distributed throughout. There are nine different species of Echinacea, but only three of them are used as medicinal plants with wide therapeutic uses: Echinacea purpurea (L.) Moench, Echinacea pallida (Nutt.) Nutt. and Echinacea angustifolia DC. Several significant groups of bioactive compounds with pharmacological activities have been isolated from Echinacea species. Numerous beneficial effects have been demonstrated about these compounds. The immunomodulatory effect was initially demonstrated, but over time other effects have also been highlighted. The present review gives a comprehensive summary of the chemical constituents, bioactive compounds, biological effects and therapeutical uses of purple coneflower. Research shows that such a well-known and recognized species needs to be further studied to obtain efficient products with a guarantee of the safety.

Electrosprayed Nanoparticles Containing Hydroalcoholic Extract of Echinacea purpurea (L.) Moench Stimulates Immune System by Increasing Inflammatory Factors in Male Wistar Rats.

Purpose: Echinacea purpurea (L.) Moench is a member of the Asteraceae family and is traditionally used mainly due to its immunostimulatory properties. Various compounds including alkylamides and chicoric acid were reported as active ingredients of E. purpurea. Here, we aimed to prepare electrosprayed nanoparticles (NPs) containing hydroalcoholic extract of E. purpurea using Eudragit RS100 (EP-Eudragit RS100 NPs) to improve the immunomodulatory effects of the extract. Methods: The EP-Eudragit RS100 NPs with the different extract:polymer ratios and solution concentrations were prepared using the electrospray technique. The size and morphology of the NPs were evaluated using dynamic light scattering (DLS) and field emission-scanning electron microscopy (FE-SEM). To evaluate the immune responses, male Wistar rats were administrated with the prepared EP-Eudragit RS100 NPs and plain extract in the final dose of 30 or 100 mg/kg. The blood samples of the animals were collected and the inflammatory factors and complete blood count (CBC) were investigated. Results: In vivo studies indicated that the plain extract and EP-Eudragit RS100 NPs (100 mg/kg) significantly increased the serum level of tumor necrosis factor-α (TNF-α) and interleukin 1-β (IL1-β) whereas the EP-Eudragit RS100 NPs (30 mg/kg) significantly increased the number of white blood cells (WBCs) compared to the control group. Lymphocytes' count in all groups was increased significantly compared to the control group (P<0.05) whereas other CBC parameters remained unchanged. Conclusion: The prepared EP-Eudragit RS100 NPs by electrospray technique caused significant reinforcement in the immunostimulatory effects of the extract of E. purpurea.

Echinacea Purpurea For the Long-Term Prevention of Viral Respiratory Tract Infections During Covid-19 Pandemic: A Randomized, Open, Controlled, Exploratory Clinical Study.

SARS-CoV-2 vaccination is effective in preventing severe Covid-19, but efficacy in reducing viral load and transmission wanes over time. In addition, the emergence of novel SARS-CoV-2 variants increases the threat of uncontrolled dissemination and additional antiviral therapies are urgently needed for effective containment. In previous in vitro studies Echinacea purpurea demonstrated strong antiviral activity against enveloped viruses, including SARS-CoV-2. In this study, we examined the potential of Echinacea purpurea in preventing and treating respiratory tract infections (RTIs) and in particular, SARS-CoV-2 infections. 120 healthy volunteers (m,f, 18—75 years) were randomly assigned to Echinacea prevention or control group without any intervention. After a run-in week, participants went through 3 prevention cycles of 2, 2 and 1 month with daily 2,400 mg Echinacea purpurea extract (Echinaforce®, EF). The prevention cycles were interrupted by breaks of 1 week. Acute respiratory symptoms were treated with 4,000 mg EF for up to 10 days, and their severity assessed via a diary. Naso/oropharyngeal swabs and venous blood samples were routinely collected every month and during acute illnesses for detection and identification of respiratory viruses, including SARS-CoV-2 via RT-qPCR and serology. Summarized over all phases of prevention, 21 and 29 samples tested positive for any virus in the EF and control group, of which 5 and 14 samples tested SARS-CoV-2 positive (RR = 0.37, Chi-square test, p = 0.03). Overall, 10 and 14 symptomatic episodes occurred, of which 5 and 8 were Covid-19 (RR = 0.70, Chi-square test, p > 0.05). EF treatment when applied during acute episodes significantly reduced the overall virus load by at least 2.12 log10 or approx. 99% (t-test, p < 0.05), the time to virus clearance by 8.0 days for all viruses (Wilcoxon test, p = 0.02) and by 4.8 days for SARS-CoV-2 (p > 0.05) in comparison to control. Finally, EF treatment significantly reduced fever days (1 day vs 11 days, Chi-square test, p = 0.003) but not the overall symptom severity. There were fewer Covid-19 related hospitalizations in the EF treatment group (N = 0 vs N = 2). EF exhibited antiviral effects and reduced the risk of viral RTIs, including SARS-CoV-2. By substantially reducing virus loads in infected subjects, EF offers a supportive addition to existing mandated treatments like vaccinations. Future confirmatory studies are warranted.

In-depth investigation of the mechanisms of Echinacea purpurea polysaccharide mitigating alcoholic liver injury in mice via gut microbiota informatics and liver metabolomics

Accumulating evidence suggests that the pathogenesis of alcoholic liver disease (ALD) is strongly correlated with abnormalities of the gut-liver axis. Echinacea purpurea polysaccharide (EPP) is a homogeneous polysaccharide, which has been shown to mitigate ALD. However, the effects of EPP on gut microbiome and consequently on hepatic metabolism have yet to be explored. In this study, the microbiome and metabolomics were combined to explore the effects of EPP on gut microbiota and hepatic metabolism, and the relationship between both was further revealed by Spearman correlation analysis. Results exhibited EPP reversed alcohol-induced disturbances in gut microbiota, evidenced by increased abundance of Muribaculaceae, Lactobacillus, and Bacteroides and decreased abundance of Escherichia_Shigella and Enterococcus. Besides, EPP promoted the production of n-butyric acid, a short-chain fatty acid that maintains the integrity of the intestinal barrier. Moreover, EPP improved alterations in hepatic metabolites, and characteristic metabolites such as Berberine and Ponasterone as well as key metabolic pathways, particularly Nitrogen metabolism, were identified. Furthermore, correlation analysis suggested significant associations between gut microbes and hepatic metabolites, which in turn confirmed EPP alleviated ALD via the gut-liver axis. Therefore, these findings elucidated in-depth mechanisms of EPP against ALD and provided a new target for intervention in alcohol-related diseases.